• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply
Sort by Relevance
CSV RIS
Search Results [15895 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2014 NIHR Health Technology Assessment programme The opportunities and challenges of pragmatic point-of-care randomised trials using routinely collected electronic records: evaluations of two exemplar trials
2014 NIHR Health Technology Assessment programme Routine echocardiography in the management of stroke and transient ischaemic attack: a systematic review and economic evaluation
2014 Blue Cross Blue Shield Association (BCBS) CYP2D6 pharmacogenomics of tamoxifen treatment
2014 NIHR Health Technology Assessment programme A systematic review of the effectiveness and cost-effectiveness of sensory, psychological and behavioural interventions for managing agitation in older adults with dementia
2014 NIHR Health Technology Assessment programme Systematic review to identify and appraise outcome measures used to evaluate childhood obesity treatment interventions (CoOR): evidence of purpose, application, validity, reliability and sensitivity
2014 NIHR Health Technology Assessment programme Vitamin D supplementation in pregnancy: a systematic review
2014 Agency for Healthcare Research and Quality (AHRQ) Pharmacologic therapies for the management of Crohn's disease: comparative effectiveness
2014 NIHR Health Technology Assessment programme Assessing methods to specify the target difference for a randomised controlled trial: DELTA (Difference ELicitation in TriAls) review
2014 NIHR Health Technology Assessment programme Assessment of the feasibility and clinical value of further research to evaluate the management options for children with Down syndrome and otitis media with effusion: a feasibility study
2014 NIHR Health Technology Assessment programme Systematic reviews of and integrated report on the quantitative, qualitative and economic evidence base for the management of obesity in men
2014 NIHR Health Technology Assessment programme Changing eating behaviours to treat childhood obesity in the community using mandolean: the community mandolean randomised trial (COMMANDO), a pilot study
2014 German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Effectiveness and efficacy of minimally invasive lung volume reduction surgery for emphysema]
2014 NIHR Health Technology Assessment programme Optical coherence tomography for the diagnosis, monitoring and guiding of treatment for neovascular age-related macular degeneration: a systematic review and economic evaluation
2014 NIHR Health Technology Assessment programme Adenoidectomy with or without grommets for children with otitis media: an individual patient data meta-analysis
2014 NIHR Health Technology Assessment programme A systematic review and economic evaluation of diagnostic strategies for Lynch syndrome
2014 NIHR Health Technology Assessment programme Preparatory study for the Re-valuation of the EQ-5D Tariff
2014 NIHR Health Technology Assessment programme A systematic review, psychometric analysis and qualitative assessment of generic preference-based measures of health in mental health populations and the estimation of mapping functions from widely specific measures
2014 NIHR Health Technology Assessment programme Percutaneous vertebroplasty and percutaneous balloon kyphoplasty for the treatment of osteoporotic vertebral fractures: a systematic review and cost-effectiveness analysis
2014 Health Technology and Policy Unit (HTPU) Assisted reproductive technologies (ARTs)
2014 The Swedish Council on Health Technology Assessment (SBU) [Diagnostic imaging in suspected prostate cancer]
2014 The Swedish Council on Health Technology Assessment (SBU) [Diagnostic imaging in the staging of prostate cancer]
2014 The Swedish Council on Health Technology Assessment (SBU) [Occupational Exposures and Back Disorders]
2014 The Swedish Council on Health Technology Assessment (SBU) [Occupational exposures and symptoms of depression and burnout]
2014 The Swedish Council on Health Technology Assessment (SBU) [Dyslexia in children and adolescents – tests and interventions]
2014 The Swedish Council on Health Technology Assessment (SBU) [Chronic ulcers in the elderly – prevention and treatment]
2014 Scottish Health Technologies Group (SHTG) What is the clinical and cost effectiveness of treatment with renal denervation for patients with resistant hypertension?
2014 German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Clinical effectiveness and cost-effectiveness of fissure sealants in children and adolescents with a high caries risk]
2014 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Clinical effectiveness of newborn screening for inborn errors of metabolism. Part II: Methylmalonic acidemia, Propionic acidemia, Tyrosinemia type I]
2014 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Irreversible electroporation in pancreatic and liver cancer]
2014 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Photopheresis in treatment of steroid-refractory acute graft-versus-host disease]
2014 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Safety and efficacy of mechanical thrombectomy using stents retrievers in the treatment of acute isquemic stroke]
2014 NIHR Health Technology Assessment programme Canagliflozin in combination therapy for treating type 2 diabetes
2014 NIHR Health Technology Assessment programme Afatinib for treating epidermal growth factor receptor mutation positive locally advanced or metastatic non-small cell lung cancer
2014 NIHR Health Technology Assessment programme Eculizumab for treating atypical haemolytic uraemic syndrome
2014 NIHR Health Technology Assessment programme Radium-223 dichloride for treating metastatic hormone relapsed prostate cancer with bone metastases
2014 NIHR Health Technology Assessment programme Enzalutamide for the treatment of metastatic hormone relapsed prostate cancer previously treated with a docetaxel-containing regimen
2014 NIHR Health Technology Assessment programme The effectiveness of sexual health interventions for people with severe mental illness: a systematic review
2014 NIHR Health Technology Assessment programme START (STrAtegies for RelaTives) study: a pragmatic randomised controlled trial to determine the clinical effectiveness and cost-effectiveness of a manual-based coping strategy programme in promoting the mental health of carers of people with dementia
2014 NIHR Health Technology Assessment programme The use of fenestrated and branched endovascular aneurysm repair (fEVAR & bEVAR) for juxta-renal and thoraco-abdominal aneurysms: a systematic review and cost effectiveness analysis
2014 NIHR Health Technology Assessment programme Clinical effectiveness of interventions for treatment-resistant anxiety in older people; a systematic review
2014 NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of second-eye cataract surgery: a systematic review and economic evaluation
2014 NIHR Health Technology Assessment programme KRAS mutation testing of tumours in adults with metastatic colorectal cancer: a systematic review and cost-effectiveness analysis
2014 NIHR Health Technology Assessment programme The clinical and cost-effectiveness of lenalidomide for people who have received at least one prior therapy with bortezomib (partial review of TA171)
2014 NIHR Health Technology Assessment programme Ipilimumab for previously untreated unresectable malignant melanoma: a single technology appraisal
2014 NIHR Health Technology Assessment programme The design of a survey questionnaire to measure perceptions and behaviour during an influenza pandemic: the Flu TElephone Survey Template (FluTEST)
2014 NIHR Health Technology Assessment programme Ivacaftor for the treatment of patients with cystic fibrosis and the G551D mutation: a systematic review and cost-effectiveness analysis
2014 NIHR Health Technology Assessment programme Allopurinol for chronic kidney disease: a systematic review
2014 NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of peginterferon alfa and ribavirin for the treatment of chronic hepatitis C in children and young people: a systematic review and economic evaluation
2014 NIHR Health Technology Assessment programme What is the clinical effectiveness and cost-effectiveness of cytisine compared with varenicline for smoking cessation? A systematic review and economic evaluation
2014 NIHR Health Technology Assessment programme Interventions for adult eustachian tube dysfunction: a systematic review
2014 NIHR Health Technology Assessment programme Epidermal growth factor receptor tyrosine kinase (EGFR-TK) mutation testing in adults with locally advanced or metastatic non-small cell lung cancer: a systematic review and cost-effectiveness analysis
2014 NIHR Health Technology Assessment programme Clinical and cost-effectiveness of cholecystectomy versus observation/conservative management for preventing recurrent symptoms and complications in adults presenting with uncomplicated symptomatic gallstones or cholecystitis: a systematic review and economic evaluation
2014 NIHR Health Technology Assessment programme Effectiveness and cost-effectiveness of traditional and new partner notification technologies for curable sexually transmitted infections: observational study, systematic reviews and mathematical modelling
2014 NIHR Health Technology Assessment programme T-DM1 for treating HER2-positive, unresectable locally advanced or metastatic breast cancer after treatment with trastuzumab and a taxane
2014 Scottish Health Technologies Group (SHTG) Transcatheter aortic valve implantation (TAVI) for severe symptomatic aortic stenosis in adults at high surgical risk
2014 Scottish Health Technologies Group (SHTG) Transcatheter aortic valve implantation (TAVI) for severe symptomatic aortic stenosis in adults who are not eligible for surgery
2014 Scottish Health Technologies Group (SHTG) Are homeopathic remedies clinically and cost effective in the treatment of migraine and osteoarthritis?
2014 NIHR Health Technology Assessment programme Adenoidectomy with or without grommets for children with otitis media: an individual patient data meta-analysis
2014 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Development of appropriateness criteria for transcatheter aortic valve implantation (TAVI) for severe symptomatic aortic stenosis]
2014 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Intraoperative radiotherapy in colorectal cancer]
2014 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Review of the indications of stereotactic body radiation therapy (SBRT) in patients with primary tumours and oligometastases]
2014 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Transvaginal mesh in pelvic organ prolapse repair]
2014 NIHR Health Technology Assessment programme Sofosbuvir for treating chronic hepatitis C
2014 NIHR Health Technology Assessment programme Lubiprostone for chronic idiopathic constipation [ID725]
2014 NIHR Health Technology Assessment programme Abiraterone acetate for the treatment of chemotherapy naive metastatic castration-resistant prostate cancer (ID503)
2014 Agenzia nazionale per i servizi sanitari regionali (Agenas) Implantable cardiac resynchronization therapy and defibrillator (CRT-D) in patients with heart failure. Rapid HTA Report
2014 Agenzia nazionale per i servizi sanitari regionali (Agenas) Ultrasonic energy devices for surgery
2014 NIHR Health Technology Assessment programme Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: a systematic review, statistical modelling and survey
2014 NIHR Health Technology Assessment programme The clinical effectiveness, cost-effectiveness and acceptability of community-based interventions aimed at improving or maintaining quality of life in children of parents with serious mental illness: a systematic review
2014 Scottish Health Technologies Group (SHTG) In the context of hypothyroidism, what is the evidence for the effectiveness of diagnostic tests and thyroid hormone replacement therapies?
2014 Technology Assessment at SickKids (TASK) The cost-effectiveness of clinic-based chloral hydrate sedation versus general anaesthesia for paediatric ophthalmological procedures
2014 NIHR Health Technology Assessment programme Imatinib for the adjuvant treatment of gastrointestinal stromal tumours
2014 Agency for Healthcare Research and Quality (AHRQ) Primary care screening for abdominal aortic aneurysm: a systematic evidence review for the U.S. preventive services task force
2014 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Atomoxetine (Strattera®)
2014 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Abatacept (Orencia®)
2014 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Linaclotide (Constella®)
2014 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Nalmefene (Selincro®)
2014 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Nab-Paclitaxel (Abraxane®, Ebetaxel®) as first-line therapy for metastatic adenocarcinoma of the pancreas
2014 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Alpharadin, radium-223 Chloride (Xofigo®) for the treatment of patients with symptomatic hormone refractory prostate cancer with skeletal metastases
2014 The Swedish Council on Health Technology Assessment (SBU) [Aromatase inhibitors for early-stage breast cancer]
2014 HAYES, Inc. Computerized Neurocognitive Testing (CNT) for sports-related head injury
2014 HAYES, Inc. High-frequency chest wall compression for diseases other than cystic fibrosis
2014 HAYES, Inc. Intrathecal opioids for chronic noncancer pain
2014 HAYES, Inc. Intravenous immunoglobulin for rheumatic diseases
2014 HAYES, Inc. Intravenous vitamin C for the treatment of cancer
2014 HAYES, Inc. Percutaneous mitral valve repair
2014 HAYES, Inc. Positron Emission Tomography (PET) for metastatic melanoma
2014 HAYES, Inc. Robotically assisted hysterectomy
2014 HAYES, Inc. Sensory integration therapy for non-autistic children
2014 HAYES, Inc. Smoking cessation in patients with schizophrenia
2014 HAYES, Inc. The use of Information Communication Technology (ICT) to improve treatment adherence in patients with diabetes
2014 HAYES, Inc. Transcranial direct current stimulation for depression
2014 HAYES, Inc. Transcranial magnetic stimulation for treatment-resistant depression
2014 HAYES, Inc. Transcranial Magnetic Stimulation (TMS) to enhance pharmacotherapy for depression
2014 HAYES, Inc. Afirma thyroid FNA analysis
2014 HAYES, Inc. ERCC1 expression analysis in Non-Small Cell Lung Cancer (NSCLC)
2014 HAYES, Inc. HERmark breast cancer assay
2014 HAYES, Inc. Immunoglobulin gene testing for B-cell leukemia
2014 HAYES, Inc. L1 syndrome (L1CAM-related disorders)
2014 HAYES, Inc. PTEN gene expression testing in Non-Small Cell Lung Cancer (NSCLC)